Neuropilin-1 (NRP-1) and Magnetic Nanoparticles, a Potential Combination for Diagnosis and Therapy of Gliomas

Curr Pharm Des. 2015;21(37):5434-49. doi: 10.2174/1381612821666150917092658.

Abstract

In this review, Neuropilin-1 (NRP-1) has been focused as a novel molecular target for potential treatment of gliomas. The properties of NRP-1 were described briefly. The role of NRP-1 in gliomas was explored in details, including relationships of NRP-1 expression and glioma prognosis, Sema3A-NRP-1 signaling in gliomas, NRP-1 signaling and VEGF/VEGFR, PlGF, TGF-β, PDGF, LD22-4 of FGF2, autocrine of HGF/SF, p130Cas tyrosine phosphorylation and integrin-associated tumor microenvironment in gliomas, NRP-1 intracellular trafficking, NRP-1 and glioma stem-like cells, as well as magnetic nanoparticles related to targeting gliomas. NRP-1, a multifunctional-receptors protein, would mediate diverse cellular signaling pathways in gliomas, and might potentially act as a novel therapeutic target. In future, magnetic nanoparticles coated with NRP-1 may play a vital role on diagnosis and therapy of gliomas.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / metabolism
  • Glioma / diagnosis
  • Glioma / drug therapy*
  • Glioma / metabolism
  • Humans
  • Magnetite Nanoparticles / administration & dosage
  • Magnetite Nanoparticles / chemistry*
  • Neuropilin-1 / administration & dosage
  • Neuropilin-1 / chemistry*
  • Neuropilin-1 / metabolism
  • Protein Transport / physiology
  • Signal Transduction / physiology

Substances

  • Magnetite Nanoparticles
  • Neuropilin-1